Barclays PLC Sight Sciences, Inc. Transaction History

Barclays PLC

$357 Billion
Q4 2024

A detailed history of Barclays PLC transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Barclays PLC holds 56,294 shares of SGHT stock, worth $167,756. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,294

Previous 50,300 11.92%

Holding current value

$167,756

Previous $317,000 35.33%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$3.36 - $6.18 $20,139 - $37,042	5,994 Added 11.92%	56,294 $205,000
Q3 2024 Nov 15, 2024	BUY	$5.49 - $8.31 $209,981 - $317,840	38,248 Added 317.36%	50,300 $317,000
Q2 2024 Aug 14, 2024	SELL	$5.13 - $7.15 $16,349 - $22,787	-3,187 Reduced 20.91%	12,052 $80,000
Q1 2024 May 15, 2024	SELL	$4.02 - $5.89 $58,233 - $85,322	-14,486 Reduced 48.73%	15,239 $80,000
Q4 2023 Feb 15, 2024	BUY	$1.29 - $5.86 $25,904 - $117,674	20,081 Added 208.22%	29,725 $153,000
Q2 2023 Aug 03, 2023	SELL	$7.46 - $10.67 $10,555 - $15,098	-1,415 Reduced 12.8%	9,644 $80,000
Q1 2023 May 04, 2023	BUY	$8.44 - $13.35 $43,963 - $69,540	5,209 Added 89.04%	11,059 $96,000
Q4 2022 Feb 13, 2023	BUY	$5.58 - $13.94 $27,548 - $68,821	4,937 Added 540.74%	5,850 $72,000
Q3 2022 Nov 03, 2022	SELL	$6.1 - $11.41 $1,024 - $1,916	-168 Reduced 15.54%	913 $6,000
Q2 2022 Aug 12, 2022	SELL	$6.61 - $11.99 $22,850 - $41,449	-3,457 Reduced 76.18%	1,081 $10,000
Q1 2022 May 16, 2022	BUY	$11.56 - $17.9 $52,459 - $81,230	4,538 New	4,538 $53,000

Others Institutions Holding SGHT

# of Institutions

Shares Held

22.4M

Call Options Held

62.8K

Put Options Held

900

View Full List

About Sight Sciences, Inc.

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $143M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

More about SGHT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account